Managing Concurrent Wet AMD and GA

Ted Leng, MD

Show Description +

Ted Leng, MD, explains a recent IRIS Registry analysis of anti-VEGF therapy patterns and outcomes for patients with both wet AMD and geographic atrophy.

Posted: 5/17/2024

Keywords:

retina-meeting-recap

•

Anti-VEGF

•

Geographic Atrophy (GA)

•

Age-Related Macular Degeneration (AMD)

•

Wet AMD

•

IRIS registry

Up Next

Name: Managing Concurrent Wet AMD and GA
Uploaded: 2024-05-17T15:15:21+00:00
Description: Ted Leng, MD, explains a recent IRIS Registry analysis of anti-VEGF therapy patterns and outcomes for patients with both wet AMD and geographic atrophy.

A Look at Three-Year Data for Pegcetacoplan

Ashkan Abbey, MD

The Latest Data on Photobiomodulation

Todd Schneiderman, MD

A Subretinal Implant for GA: Improving Vision

Mahi Muqit, MD

Optogenetics for RP: 12-Month Data

Allen Ho, MD

New Data on Oral DR Therapy

Daniel Su, MD

Outcomes with 8 mg Aflibercept: Does Prior DME Treatment Matter?

Nitish Mehta, MD

Imaging AMD: Microperimetry and OCT

Giulia Corradetti, MD

SriniVas R. Sadda, MD, Steps in as ARVO President

Vas Sadda, MD

Gene Therapy for Wet AMD: Pharmacodynamic Changes

Ramanath Bhandari, MD

Faricimab in the Real World: 2 Years of Data

Aamir Aziz, MD

Addressing the AMD Epidemic

Emily Chew, MD

Back to All Videos

Managing Concurrent Wet AMD and GA

Ted Leng, MD

Ted Leng, MD, explains a recent IRIS Registry analysis of anti-VEGF therapy patterns and outcomes for patients with both wet AMD and geographic atrophy.

Posted: 5/17/2024

Keywords:

retina-meeting-recap

•

Anti-VEGF

•

Geographic Atrophy (GA)

•

Age-Related Macular Degeneration (AMD)

•

Wet AMD

•

IRIS registry

Please log in to leave a comment.

Meeting Coverage:

Association for Research in Vision & Ophthalmology

Managing Concurrent Wet AMD and GA

Up Next

Managing Concurrent Wet AMD and GA

More From ARVO: 2024 Coverage